Sandy Draper
Stock Analyst at Guggenheim
(2.91)
# 1,726
Out of 5,045 analysts
119
Total ratings
59.38%
Success rate
20.16%
Average return
Main Sectors:
Stocks Rated by Sandy Draper
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MEDP Medpace Holdings | Maintains: Buy | $464 → $432 | $580.37 | -25.56% | 12 | Jul 24, 2024 | |
| IQV IQVIA Holdings | Downgrades: Neutral | n/a | $216.47 | - | 8 | Feb 15, 2024 | |
| CRL Charles River Laboratories International | Downgrades: Neutral | n/a | $179.11 | - | 15 | Feb 15, 2024 | |
| EVH Evolent Health | Maintains: Hold | $36 → $34 | $6.60 | +415.15% | 9 | Nov 14, 2023 | |
| GDRX GoodRx Holdings | Maintains: Buy | $8 → $10 | $3.44 | +190.70% | 4 | Aug 10, 2023 | |
| DOCS Doximity | Downgrades: Neutral | n/a | $65.82 | - | 3 | Aug 9, 2023 | |
| TOI The Oncology Institute | Maintains: Buy | $3 → $2 | $4.59 | -56.43% | 3 | Jun 16, 2023 | |
| ICLR ICON Public Limited Company | Maintains: Buy | $271 → $263 | $165.33 | +59.08% | 13 | Apr 28, 2023 | |
| AGL agilon health | Maintains: Buy | $21 → $30 | $0.80 | +3,650.00% | 3 | Mar 6, 2023 | |
| HQY HealthEquity | Maintains: Buy | $89 → $94 | $92.95 | +1.13% | 11 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $8.74 | - | 10 | Oct 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $51 | $24.51 | +108.08% | 2 | Aug 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $143 → $129 | $193.22 | -33.24% | 2 | May 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $84 → $55 | $35.33 | +55.68% | 2 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $226 → $168 | $63.22 | +165.74% | 2 | May 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $12 | $44.06 | -72.76% | 1 | Apr 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $33 → $38 | $28.14 | +35.04% | 7 | Feb 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $9.51 | +425.76% | 1 | Jan 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $65 | $9.69 | +570.79% | 1 | Jan 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $36 | $3.28 | +997.56% | 4 | May 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $175 → $167 | $285.03 | -41.41% | 3 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $1.40 | - | 2 | May 31, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $63 | $12.85 | +390.27% | 1 | Sep 20, 2016 |
Medpace Holdings
Jul 24, 2024
Maintains: Buy
Price Target: $464 → $432
Current: $580.37
Upside: -25.56%
IQVIA Holdings
Feb 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $216.47
Upside: -
Charles River Laboratories International
Feb 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $179.11
Upside: -
Evolent Health
Nov 14, 2023
Maintains: Hold
Price Target: $36 → $34
Current: $6.60
Upside: +415.15%
GoodRx Holdings
Aug 10, 2023
Maintains: Buy
Price Target: $8 → $10
Current: $3.44
Upside: +190.70%
Doximity
Aug 9, 2023
Downgrades: Neutral
Price Target: n/a
Current: $65.82
Upside: -
The Oncology Institute
Jun 16, 2023
Maintains: Buy
Price Target: $3 → $2
Current: $4.59
Upside: -56.43%
ICON Public Limited Company
Apr 28, 2023
Maintains: Buy
Price Target: $271 → $263
Current: $165.33
Upside: +59.08%
agilon health
Mar 6, 2023
Maintains: Buy
Price Target: $21 → $30
Current: $0.80
Upside: +3,650.00%
HealthEquity
Dec 7, 2022
Maintains: Buy
Price Target: $89 → $94
Current: $92.95
Upside: +1.13%
Oct 24, 2022
Upgrades: Neutral
Price Target: n/a
Current: $8.74
Upside: -
Aug 12, 2022
Maintains: Buy
Price Target: $36 → $51
Current: $24.51
Upside: +108.08%
May 25, 2021
Maintains: Buy
Price Target: $143 → $129
Current: $193.22
Upside: -33.24%
May 18, 2021
Maintains: Buy
Price Target: $84 → $55
Current: $35.33
Upside: +55.68%
May 12, 2021
Maintains: Buy
Price Target: $226 → $168
Current: $63.22
Upside: +165.74%
Apr 21, 2021
Initiates: Hold
Price Target: $12
Current: $44.06
Upside: -72.76%
Feb 4, 2021
Maintains: Hold
Price Target: $33 → $38
Current: $28.14
Upside: +35.04%
Jan 28, 2021
Initiates: Buy
Price Target: $50
Current: $9.51
Upside: +425.76%
Jan 28, 2021
Initiates: Buy
Price Target: $65
Current: $9.69
Upside: +570.79%
May 13, 2020
Maintains: Buy
Price Target: $30 → $36
Current: $3.28
Upside: +997.56%
Mar 26, 2020
Maintains: Buy
Price Target: $175 → $167
Current: $285.03
Upside: -41.41%
May 31, 2017
Upgrades: Buy
Price Target: n/a
Current: $1.40
Upside: -
Sep 20, 2016
Initiates: Buy
Price Target: $63
Current: $12.85
Upside: +390.27%